Cash flow Biogen Inc.

Equities

BIIB

US09062X1037

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 13/02/2026 GMT			5-day change	1st Jan Change
196.52 ^USD	+0.52%		-2.32%	+11.67%

02-13	Biogen Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-13-2026 10:30 AM
02-12	Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap…

00d0779a7edecb7a032c114d0e17.-y_GWiv7KgRJ2odTOX069iJSWiaEqCm59VUcXOQO3s8.s16EGETOXlcokL5hVhRul041O1PWzlPJhi0kD5JZk76uWa4oYohmYT6W7A

Published financial data: BIOGEN INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	10.51B	9.69B	9.84B	9.68B	9.89B
Other Revenues, Total	476M	485M	-	-	-
Total Revenues	10.98B	10.17B	9.84B	9.68B	9.89B
Cost of Goods Sold, Total	2.11B	2.28B	2.53B	2.31B	2.08B
Gross Profit	8.87B	7.9B	7.3B	7.37B	7.81B
Selling General & Admin Expenses, Total	2.68B	2.41B	2.5B	2.39B	2.43B
R&D Expenses	2.5B	2.23B	2.46B	2.02B	1.75B
Amortization of Goodwill and Intangible Assets - (IS)	252M	246M	241M	386M	507M
Other Operating Expenses	7.2M	-7.4M	219M	254M	290M
Other Operating Expenses, Total	5.44B	4.88B	5.42B	5.04B	4.98B
Operating Income	3.44B	3.01B	1.88B	2.32B	2.82B
Interest Expense, Total	-254M	-247M	-247M	-250M	-268M
Interest And Investment Income	11M	89.3M	276M	67.6M	125M
Net Interest Expenses	-243M	-157M	29.6M	-183M	-142M
Income (Loss) On Equity Invest.	34.9M	2.6M	-	-	-
Currency Exchange Gains (Loss)	-22.4M	-35.5M	-50.4M	-30.9M	-28.6M
Other Non Operating Income (Expenses)	-4M	-3M	-1.7M	-26.5M	29.4M
EBT, Excl. Unusual Items	3.2B	2.82B	1.86B	2.08B	2.68B
Restructuring Charges	-	-131M	-243M	-73.9M	-78.4M
Merger & Related Restructuring Charges	-	-	-28.4M	-2.8M	-217M
Gain (Loss) On Sale Of Investments	-825M	1.23B	-291M	-100M	-19.7M
Gain (Loss) On Sale Of Assets	-	504M	-	88.6M	-
Asset Writedown	-629M	-120M	-	-60.2M	-60.8M
In Process R&D Expenses	-18M	-	-	-	-472M
Legal Settlements	-	-917M	-	-	-244M
Other Unusual Items	50.7M	209M	-	-27.7M	-33.6M
EBT, Incl. Unusual Items	1.78B	3.59B	1.3B	1.91B	1.56B
Income Tax Expense	52.5M	633M	135M	274M	264M
Earnings From Continuing Operations	1.73B	2.96B	1.16B	1.63B	1.29B
Net Income to Company	1.73B	2.96B	1.16B	1.63B	1.29B
Minority Interest	-172M	85.3M	-400K	-	-
Net Income - (IS)	1.56B	3.05B	1.16B	1.63B	1.29B
Net Income to Common Incl Extra Items	1.56B	3.05B	1.16B	1.63B	1.29B
Net Income to Common Excl. Extra Items	1.56B	3.05B	1.16B	1.63B	1.29B
Per Share Items
Net EPS - Basic	10.44	20.97	8.02	11.21	8.83
Basic EPS - Continuing Operations	10.44	20.97	8.02	11.21	8.83
Basic Weighted Average Shares Outstanding	149M	145M	145M	146M	146M
Net EPS - Diluted	10.4	20.87	7.97	11.18	8.79
Diluted EPS - Continuing Operations	10.4	20.87	7.97	11.18	8.79
Diluted Weighted Average Shares Outstanding	150M	146M	146M	146M	147M
Normalized Basic EPS	12.27	12.72	8.03	8.94	11.44
Normalized Diluted EPS	12.23	12.66	7.98	8.92	11.4
American Depositary Receipts Ratio (ADR)	0.17	0.17	0.17	0.17	0.17
Supplemental Items
EBITDA	3.92B	3.53B	2.38B	3B	3.6B
EBITA	3.69B	3.26B	2.12B	2.71B	3.33B
EBIT	3.44B	3.01B	1.88B	2.32B	2.82B
EBITDAR	4.02B	3.63B	2.52B	3.12B	3.73B
Total Revenues (As Reported)	10.98B	10.17B	9.84B	9.68B	9.89B
Effective Tax Rate - (Ratio)	2.95	17.61	10.43	14.37	16.94
Current Domestic Taxes	342M	734M	393M	499M	57.4M
Current Foreign Taxes	137M	67.9M	48.4M	-67.5M	-155M
Total Current Taxes	479M	801M	441M	432M	-98M
Deferred Domestic Taxes	-254M	-326M	-600M	-172M	321M
Deferred Foreign Taxes	-172M	157M	294M	13.7M	40.6M
Total Deferred Taxes	-427M	-169M	-306M	-158M	362M
Normalized Net Income	1.83B	1.85B	1.16B	1.3B	1.68B
Interest Capitalized	36.3M	17.1M	21.7M	3.2M	3.4M
Non-Cash Pension Expense	29.1M	25.9M	21.2M	21.3M	20.7M
Supplemental Operating Expense Items
Advertising Expense	98.7M	54.1M	71.4M	66.8M	71.9M
Selling and Marketing Expenses	98.7M	54.1M	71.4M	66.8M	71.9M
Research And Development Expense From Footnotes	3.4B	2.6B	2.7B	2.49B	2.29B
Net Rental Expense, Total	97.9M	95.6M	140M	125M	123M
Imputed Operating Lease Interest Expense	29.1M	28M	42.64M	35.93M	39.73M
Imputed Operating Lease Depreciation	68.8M	67.6M	97.66M	89.37M	82.87M
Stock-Based Comp., Other (Total)	251M	264M	658M	342M	291M
Total Stock-Based Compensation	251M	264M	658M	342M	291M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.26B	3.42B	1.05B	2.38B	3.01B
Short Term Investments	1.54B	1.47B	-	-	807M
Total Cash And Short Term Investments	3.8B	4.89B	1.05B	2.38B	3.82B
Accounts Receivable, Total	1.96B	2.14B	2.1B	1.87B	1.87B
Other Receivables	-	799M	430M	-	-
Total Receivables	1.96B	2.94B	2.53B	1.87B	1.87B
Inventory	1.35B	1.34B	2.53B	2.46B	2.17B
Prepaid Expenses	-	-	-	-	694M
Other Current Assets, Total	741M	619M	752M	752M	430M
Total Current Assets	7.86B	9.79B	6.86B	7.46B	8.97B
Gross Property Plant And Equipment	5.8B	5.87B	6.13B	6.21B	6.25B
Accumulated Depreciation	-2.01B	-2.17B	-2.4B	-2.67B	-2.93B
Net Property Plant And Equipment	3.79B	3.7B	3.73B	3.54B	3.32B
Long-term Investments	2.83B	1.81B	626M	424M	954M
Goodwill	5.76B	5.75B	6.22B	6.48B	6.49B
Other Intangibles, Total	2.22B	1.85B	8.36B	9.69B	9.18B
Loans Receivable Long-Term	-	-	-	-	30M
Deferred Tax Assets Long-Term	1.42B	1.23B	929M	324M	292M
Other Long-Term Assets, Total	5.5M	426M	119M	137M	198M
Total Assets	23.88B	24.55B	26.84B	28.05B	29.44B
Liabilities
Accounts Payable, Total	589M	492M	403M	424M	432M
Accrued Expenses, Total	1.38B	1.5B	1.45B	1.5B	1.68B
Current Portion of Long-Term Debt	999M	-	150M	1.75B	-
Current Portion of Leases	89.1M	97.2M	90.3M	86.4M	80.4M
Current Income Taxes Payable	175M	260M	257M	548M	115M
Other Current Liabilities	1.06B	928M	1.08B	1.22B	1.04B
Total Current Liabilities	4.3B	3.27B	3.43B	5.53B	3.35B
Long-Term Debt	6.27B	6.28B	6.79B	4.55B	6.29B
Long-Term Leases	330M	333M	400M	334M	290M
Deferred Tax Liability Non Current	694M	335M	642M	190M	508M
Other Non Current Liabilities	1.32B	944M	781M	732M	748M
Total Liabilities	12.92B	11.17B	12.05B	11.33B	11.18B
Common Stock, Total	100K	100K	100K	100K	100K
Additional Paid In Capital	68.2M	73.3M	302M	569M	863M
Retained Earnings	13.91B	16.47B	17.63B	19.26B	20.55B
Treasury Stock	-2.98B	-2.98B	-2.98B	-2.98B	-2.98B
Comprehensive Income and Other	-107M	-165M	-154M	-136M	-182M
Total Common Equity	10.9B	13.4B	14.8B	16.72B	18.26B
Minority Interest	63.5M	-9.5M	-	-	-
Total Equity	10.96B	13.39B	14.8B	16.72B	18.26B
Total Liabilities And Equity	23.88B	24.55B	26.84B	28.05B	29.44B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	147M	144M	145M	146M	147M
ECS Total Common Shares Outstanding	147M	144M	145M	146M	147M
Book Value / Share	74.12	92.98	102.14	114.65	124.37
Tangible Book Value	2.91B	5.8B	217M	546M	2.59B
Tangible Book Value Per Share	19.82	40.24	1.5	3.74	17.62
Total Debt	7.69B	6.71B	7.43B	6.72B	6.66B
Net Debt	3B	1.11B	6.38B	4.34B	2.41B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-300K	-20.9M	-58.5M	-38.5M	-86.7M
Debt Equivalent Oper. Leases	783M	765M	1.12B	1B	981M
Minority Interest, Total (Incl. Fin. Div)	63.5M	-9.5M	-	-	-
Equity Method Investments, Total	600M	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	350M	-	-	-	-
Inventories - Work In Process, Total	814M	-	-	-	-
Inventories - Finished Goods, Total	188M	-	-	-	-
Land - (BS)	208M	202M	202M	202M	217M
Buildings, Total	1.7B	1.59B	1.6B	1.96B	2.14B
Machinery, Total	1.65B	1.67B	1.77B	2.17B	2.23B
Full Time Employees	9.61K	8.72K	7.57K	7.6K	7.5K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	2.4M	2.2M	3M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.56B	3.05B	1.16B	1.63B	1.29B
Depreciation & Amortization - CF	236M	272M	254M	287M	273M
Amortization of Goodwill and Intangible Assets - (CF)	252M	246M	241M	386M	507M
Depreciation & Amortization, Total	488M	518M	495M	673M	780M
(Gain) Loss From Sale Of Asset	-	-504M	-	-88.6M	-
(Gain) Loss on Sale of Investments - (CF)	827M	-1.24B	277M	101M	19.3M
Asset Writedown & Restructuring Costs	647M	120M	-	60.2M	146M
(Income) Loss On Equity Investments - (CF)	-34.9M	-2.6M	-	-	-
Stock-Based Compensation (CF)	239M	254M	264M	291M	291M
Other Operating Activities, Total	63.8M	81.4M	-1.3M	361M	734M
Change In Accounts Receivable	325M	-203M	61.3M	222M	103M
Change In Inventories	-462M	-320M	-131M	-274M	-64.7M
Change In Deferred Taxes	231M	-142M	-299M	78.5M	-958M
Change in Other Net Operating Assets	-239M	-224M	-280M	-182M	-138M
Cash from Operations	3.64B	1.38B	1.55B	2.88B	2.2B
Capital Expenditure	-258M	-240M	-277M	-154M	-154M
Sale of Property, Plant, and Equipment	-	583M	-	-	-
Cash Acquisitions	-	-	-6.93B	-1.07B	-
Divestitures	28.1M	-	-	-	-
Sale (Purchase) of Intangible assets	-36.8M	-2.9M	-34.4M	-118M	-31.6M
Investment in Marketable and Equity Securities, Total	-310M	1.21B	3.15B	552M	-1.18B
Other Investing Activities, Total	12.9M	24.4M	-11.3M	-4.7M	-7.1M
Cash from Investing	-564M	1.58B	-4.1B	-799M	-1.37B
Long-Term Debt Issued, Total	-	-	997M	-	1.73B
Total Debt Issued	-	-	997M	-	1.73B
Long-Term Debt Repaid, Total	-170M	-1B	-810M	-650M	-2.03B
Total Debt Repaid	-170M	-1B	-810M	-650M	-2.03B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-1.8B	-750M	-	-	-
Other Financing Activities, Total	-116M	4.9M	-38M	-33.5M	-5M
Cash from Financing	-2.09B	-1.75B	149M	-684M	-302M
Foreign Exchange Rate Adjustments	-59.8M	-55.7M	35.1M	-67.7M	102M
Net Change in Cash	930M	1.16B	-2.37B	1.33B	634M
Supplemental Items
Cash Interest Paid	281M	262M	252M	245M	264M
Cash Income Tax Paid (Refund)	248M	933M	741M	355M	864M
Levered Free Cash Flow	2.21B	1.39B	971M	3.27B	1.98B
Unlevered Free Cash Flow	2.36B	1.54B	1.13B	3.42B	2.15B
Change In Net Working Capital	226M	879M	893M	-1.23B	501M
Net Debt Issued / Repaid	-170M	-1B	187M	-650M	-297M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.86	7.78	4.58	5.29	6.14
Return on Total Capital	11.53	9.72	5.56	6.36	7.3
Return On Equity %	15.96	24.33	8.24	10.36	7.39
Return on Common Equity	14.41	25.08	8.24	10.36	7.39
Margin Analysis
Gross Profit Margin %	80.79	77.61	74.24	76.12	78.95
SG&A Margin	24.41	23.72	25.44	24.67	24.61
EBITDA Margin %	35.73	34.73	24.17	30.96	36.44
EBITA Margin %	33.58	32.05	21.58	28	33.68
EBIT Margin %	31.29	29.63	19.14	24	28.55
Income From Continuing Operations Margin %	15.73	29.11	11.81	16.87	13.07
Net Income Margin %	14.17	29.95	11.8	16.87	13.07
Net Avail. For Common Margin %	14.17	29.95	11.8	16.87	13.07
Normalized Net Income Margin	16.66	18.17	11.81	13.45	16.95
Levered Free Cash Flow Margin	20.09	13.67	9.87	33.76	20.04
Unlevered Free Cash Flow Margin	21.54	15.18	11.44	35.38	21.73
Asset Turnover
Asset Turnover	0.45	0.42	0.38	0.35	0.34
Fixed Assets Turnover	2.88	2.71	2.65	2.66	2.88
Receivables Turnover (Average Receivables)	4.9	4.73	4.64	4.88	5.3
Inventory Turnover (Average Inventory)	1.74	1.69	1.31	0.93	0.9
Short Term Liquidity
Current Ratio	1.83	2.99	2	1.35	2.68
Quick Ratio	1.34	2.39	1.04	0.77	1.7
Operating Cash Flow to Current Liabilities	0.85	0.42	0.45	0.52	0.66
Days Sales Outstanding (Average Receivables)	74.51	77.2	78.61	75.06	68.93
Days Outstanding Inventory (Average Inventory)	209.35	215.95	278.91	395.08	405.65
Average Days Payable Outstanding	79.64	86.84	43.94	67.5	87.29
Cash Conversion Cycle (Average Days)	204.22	206.31	313.58	402.64	387.29
Long Term Solvency
Total Debt/Equity	70.19	50.13	50.19	40.18	36.47
Total Debt / Total Capital	41.24	33.39	33.42	28.66	26.72
LT Debt/Equity	60.26	49.4	48.57	29.2	36.03
Long-Term Debt / Total Capital	35.41	32.91	32.34	20.83	26.4
Total Liabilities / Total Assets	54.1	45.47	44.87	40.4	37.99
EBIT / Interest Expense	13.55	12.22	7.62	9.28	10.56
EBITDA / Interest Expense	15.86	14.71	10.2	12.47	13.93
(EBITDA - Capex) / Interest Expense	14.84	13.74	9.07	11.85	13.36
Total Debt / EBITDA	1.91	1.85	2.95	2.15	1.79
Net Debt / EBITDA	0.75	0.31	2.53	1.39	0.65
Total Debt / (EBITDA - Capex)	2.04	1.98	3.32	2.26	1.86
Net Debt / (EBITDA - Capex)	0.8	0.33	2.85	1.46	0.67
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-18.32	-7.36	-3.32	-1.62	2.22
Gross Profit, 1 Yr. Growth %	-23.78	-11.01	-7.51	0.87	3.46
EBITDA, 1 Yr. Growth %	-23.26	-9.83	-32.79	26.03	11.27
EBITA, 1 Yr. Growth %	-24.9	-11.45	-34.98	27.61	12.84
EBIT, 1 Yr. Growth %	-26.2	-12.12	-37.64	23.39	10.07
Earnings From Cont. Operations, 1 Yr. Growth %	-57.45	71.43	-60.78	40.53	-20.79
Net Income, 1 Yr. Growth %	-61.1	95.8	-61.89	40.57	-20.79
Normalized Net Income, 1 Yr. Growth %	-33.27	0.93	-37.14	12.01	14.05
Diluted EPS Before Extra, 1 Yr. Growth %	-58.06	100.67	-61.81	40.28	-21.38
Accounts Receivable, 1 Yr. Growth %	-15.71	8.91	-1.7	-11.01	-0.1
Inventory, 1 Yr. Growth %	26.47	-0.53	87.99	-2.65	-11.88
Net Property, Plant and Equip., 1 Yr. Growth %	-1.38	-2.36	0.73	-5.15	-6.13
Total Assets, 1 Yr. Growth %	-3.01	2.83	9.33	4.49	4.96
Tangible Book Value, 1 Yr. Growth %	57.17	99.01	-96.25	151.34	373.93
Common Equity, 1 Yr. Growth %	1.83	22.96	10.46	12.95	9.22
Cash From Operations, 1 Yr. Growth %	-13.95	-61.97	11.77	85.85	-23.33
Capital Expenditures, 1 Yr. Growth %	-39.24	-6.9	15.27	-44.51	0.06
Levered Free Cash Flow, 1 Yr. Growth %	-23.4	-36.93	-30.3	236.43	-42.03
Unlevered Free Cash Flow, 1 Yr. Growth %	-21.52	-34.59	-27.27	204.2	-39.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-12.6	-13.01	-5.36	-2.48	0.28
Gross Profit, 2 Yr. CAGR %	-15.49	-17.64	-9.28	-3.41	3.41
EBITDA, 2 Yr. CAGR %	-28.8	-16.84	-22.16	-7.97	22.7
EBITA, 2 Yr. CAGR %	-30.11	-18.48	-24.13	-8.91	24.78
EBIT, 2 Yr. CAGR %	-31.28	-19.5	-25.98	-12.28	21.95
Earnings From Cont. Operations, 2 Yr. CAGR %	-45.84	-14.6	-18	-25.76	5.5
Net Income, 2 Yr. CAGR %	-48.59	-12.73	-13.62	-26.81	5.52
Normalized Net Income, 2 Yr. CAGR %	-35.69	-17.89	-20.35	-16.09	19.46
Diluted EPS Before Extra, 2 Yr. CAGR %	-42.47	-8.26	-12.46	-26.81	5.02
Accounts Receivable, 2 Yr. CAGR %	-10.89	-4.19	3.46	-6.47	-5.71
Inventory, 2 Yr. CAGR %	29.64	12.16	36.75	35.28	-7.38
Net Property, Plant and Equip., 2 Yr. CAGR %	1.59	-1.87	-0.82	-2.25	-5.64
Total Assets, 2 Yr. CAGR %	-6.37	-0.13	6.03	6.88	4.72
Tangible Book Value, 2 Yr. CAGR %	-15.26	76.86	-72.7	-69.32	245.13
Common Equity, 2 Yr. CAGR %	-9.63	11.9	16.54	11.7	11.07
Cash From Operations, 2 Yr. CAGR %	-28.29	-42.79	-34.8	44.13	19.37
Capital Expenditures, 2 Yr. CAGR %	-29.17	-24.79	3.6	-20.02	-25.49
Levered Free Cash Flow, 2 Yr. CAGR %	-31.03	-30.49	-33.69	53.13	42.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	-29.48	-28.37	-31.02	48.75	37.56
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-6.54	-10.89	-9.89	-4.13	-0.94
Gross Profit, 3 Yr. CAGR %	-8.65	-14.02	-14.39	-6.01	-0.37
EBITDA, 3 Yr. CAGR %	-17.61	-23.01	-22.51	-8.6	0.63
EBITA, 3 Yr. CAGR %	-18.23	-24.41	-24.37	-9.77	0.67
EBIT, 3 Yr. CAGR %	-18.57	-25.45	-26.03	-12.24	-2.2
Earnings From Cont. Operations, 3 Yr. CAGR %	-27.18	-20.47	-34.11	-1.88	-24.14
Net Income, 3 Yr. CAGR %	-29.45	-19.72	-33.79	1.6	-24.85
Normalized Net Income, 3 Yr. CAGR %	-22.09	-25.23	-24.89	-10.76	-3.21
Diluted EPS Before Extra, 3 Yr. CAGR %	-21.6	-12.75	-31.5	2.44	-25.04
Accounts Receivable, 3 Yr. CAGR %	-7.58	-4.73	-3.37	-1.6	-4.39
Inventory, 3 Yr. CAGR %	13.27	18.68	33.24	22.11	17.27
Net Property, Plant and Equip., 3 Yr. CAGR %	1.73	0.26	-1.01	-2.29	-3.56
Total Assets, 3 Yr. CAGR %	-1.9	-3.39	2.93	5.51	6.24
Tangible Book Value, 3 Yr. CAGR %	-11.57	12.64	-51.07	-42.78	-23.59
Common Equity, 3 Yr. CAGR %	-5.81	0.14	11.42	15.33	10.87
Cash From Operations, 3 Yr. CAGR %	-16.21	-41.96	-28.48	-7.56	16.78
Capital Expenditures, 3 Yr. CAGR %	-30.55	-22.41	-13.28	-15.87	-13.82
Levered Free Cash Flow, 3 Yr. CAGR %	-16.56	-33.07	-30.38	13.94	12.47
Unlevered Free Cash Flow, 3 Yr. CAGR %	-15.53	-31.26	-27.97	13.12	11.57
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.83	-3.68	-6.07	-7.62	-5.96
Gross Profit, 5 Yr. CAGR %	-2.4	-5.8	-8.9	-9.93	-7.67
EBITDA, 5 Yr. CAGR %	-9.17	-11.77	-19.46	-17.29	-6.74
EBITA, 5 Yr. CAGR %	-9.52	-12.46	-20.64	-18.53	-7.45
EBIT, 5 Yr. CAGR %	-9.66	-12.53	-21.62	-20.42	-9.5
Earnings From Cont. Operations, 5 Yr. CAGR %	-14.11	2.09	-23.64	-22.63	-20.46
Net Income, 5 Yr. CAGR %	-15.92	3.71	-23.5	-22.63	-20.22
Normalized Net Income, 5 Yr. CAGR %	-11.85	-11.66	-21.38	-21.7	-9.37
Diluted EPS Before Extra, 5 Yr. CAGR %	-9.29	11.85	-18.06	-18.67	-18.73
Accounts Receivable, 5 Yr. CAGR %	2.4	-1.63	-3.31	-5.43	-4.31
Inventory, 5 Yr. CAGR %	6.18	8.29	22.14	25.06	15.2
Net Property, Plant and Equip., 5 Yr. CAGR %	8.67	3.07	0.7	-0.75	-2.89
Total Assets, 5 Yr. CAGR %	0.86	0.75	1.2	0.59	3.64
Tangible Book Value, 5 Yr. CAGR %	-8.97	7.18	-44.74	-33.05	6.89
Common Equity, 5 Yr. CAGR %	-2.14	1.22	2.56	4.61	11.28
Cash From Operations, 5 Yr. CAGR %	-4.52	-21.18	-24.21	-16.49	-12.22
Capital Expenditures, 5 Yr. CAGR %	-15.97	-22.64	-18.51	-21.47	-18.39
Levered Free Cash Flow, 5 Yr. CAGR %	-10.22	-7.41	-23.87	-6.77	-7.19
Unlevered Free Cash Flow, 5 Yr. CAGR %	-9.72	-6.83	-22.1	-6.36	-6.52